Market Research Report
Muscarinic Acetylcholine Receptor M2 - Pipeline Review, H1 2020
|Published by||Global Markets Direct||Product code||520770|
|Published||Content info||74 Pages
Delivery time: 1-2 business days
|Muscarinic Acetylcholine Receptor M2 - Pipeline Review, H1 2020|
|Published: March 31, 2020||Content info: 74 Pages||
According to the recently published report 'Muscarinic Acetylcholine Receptor M2 - Pipeline Review, H1 2020'; Muscarinic Acetylcholine Receptor M2 (CHRM2) pipeline Target constitutes close to 7 molecules.
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Muscarinic cholinergic receptor 2 is an acetylcholine receptor. It is expressed in various regions of the brain including the cerebellum, cerebral cortex, hippocampus, medulla, striatum, and thalamus, and in lung and prostate. It mediates smooth muscle contractility. Increase in M2 receptor has been associated with depression.
The report 'Muscarinic Acetylcholine Receptor M2 - Pipeline Review, H1 2020' outlays comprehensive information on the Muscarinic Acetylcholine Receptor M2 (CHRM2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
It also reviews key players involved in Muscarinic Acetylcholine Receptor M2 (CHRM2) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Pre-Registration, Phase III, Phase II and Preclinical stages are 1, 1, 4 and 1 respectively. Report covers products from therapy areas Central Nervous System, Genito Urinary System And Sex Hormones, Cardiovascular, Dermatology, Genetic Disorders and Respiratory which include indications Alzheimer's Disease, Depression, Overactive Bladder, Parkinson's Disease, Amnesia, Amyotrophic Lateral Sclerosis, Angelman Syndrome, Anxiety Disorders, Axillary Hyperhidrosis, Fragile X Syndrome, Infantile Spasm (West Syndrome), Movement Disorders, Multiple Sclerosis, Obstructive Sleep Apnea, Pain, Psychosis, Rett Syndrome, Schizophrenia, Stroke, Tuberous Sclerosis and Urinary Incontinence.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.